PTEN-mediated pathways and their association with treatment-resistant prostate cancer.
Uzoh
Christopher C
CC
Department of Urology, Bristol Royal Infirmary, Bristol, UK. chrisc.uzoh@gmail.com
Perks
Claire M
CM
Bahl
Amit
A
Holly
Jeff M P
JM
Sugiono
Marto
M
Persad
Raj A
RA
D017209:Apoptosis / Q000502:physiology*; D019008:Drug Resistance, Neoplasm / Q000502:physiology*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local; D051058:Oncogene Protein v-akt / Q000378:metabolism*; D051059:PTEN Phosphohydrolase / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D017211:Treatment Failure
D051058:Oncogene Protein v-akt; D051059:PTEN Phosphohydrolase; C494929:PTEN protein, human